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Abstract 45 
Background: Maternal obesity has been implicated in the origins of childhood obesity through a sub-46 
optimal environment in-utero.  47 
Objective: We examined relationships of maternal early pregnancy body mass index (BMI), 48 
overweight/obesity and plasma biomarkers of obesity, inflammation, insulin resistance and placental 49 
function with measures of childhood BMI and adiposity.  50 
Methods: BMI z-score, sum of skinfold thicknesses (SST), body fat percentage (BFP, by bioelectrical 51 
impedance), waist, arm and hip circumferences were measured in 1,173 6-year-old children of nulliparous 52 
pregnant women in the SCOPE study, New Zealand. Relationships of maternal early pregnancy (15 weeks’ 53 
gestation) BMI and biomarkers with these childhood anthropometric measures were assessed by linear 54 
regression, with appropriate adjustment. 55 
Results: 28.1% of mothers were overweight and 10.1% obese; compared with normal weight mothers, 56 
the BFP of their children were 5.3% higher [0.16 SD (95% CI 0.04 to 0.29) p=0.01] and 7.8% higher [0.27 57 
(0.08 to 0.47) p=0.006] with comparable values for BMI z-score, arm, waist and hip circumferences. Early 58 
pregnancy maternal BMI and plasma placental growth factor (PlGF) were associated with higher child’s 59 
SST, BMI z-score, hip circumference and BFP. None of the metabolic or inflammatory maternal biomarkers 60 
were associated with childhood obesity.  61 
Conclusion: In this contemporary large prospective cohort study with extensive maternal/childhood 62 
phenotyping and a high prevalence of maternal overweight/obesity, we found independent relationships 63 
of maternal early pregnancy BMI with childhood BMI and adiposity, similar associations were observed 64 
with PlGF which may imply a role for placenta function in the developmental programming of childhood 65 
obesity risk. 66 
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Introduction  
The World Health Organisation (WHO) have estimated that more than 41 million children under the 
age of 5 are overweight or obese 1. The global epidemic of obesity, reflected in women of reproductive 
age and in pregnancy, has led to concerns that the metabolic consequences of maternal obesity may 
contribute to the early life determinants of childhood obesity 2–5, with most supporting evidence being 
derived from mother-child cohorts 6–11. We have also recently reported that 6-month-old children 
born to mothers in the intervention arm of a randomised controlled trial of diet and physical activity 
showed reduced adiposity suggesting that improved diet and reduced gestational weight gain in 
pregnancy could make a contribution to preventative strategies against childhood obesity 12. Policy 
makers, including the World Health Organisation now highlight nutritional status in pregnancy as a 
potentially modifiable target for prevention of childhood obesity 1. 
 
The hypothesis proposing gestational origins of childhood obesity has most frequently been tested in 
cohorts with a low prevalence of obesity, recruited prior to the current obesity epidemic, in which the 
estimation of childhood adiposity has often been limited to body mass index (BMI). The international 
Screening for Pregnancy Endpoints (SCOPE) study of 5623 primiparous women and their children 
recruited between 2004 and 2011 was one of the most detailed large prospective maternal cohorts to 
date, with 43% (n=2421) of mothers affected by overweight or obesity. Whilst primarily focusing on 
prediction of adverse pregnancy outcomes, SCOPE has offered the potential to address relationships 
between maternal obesity and childhood obesity with appropriate adjustment for social and 
environmental determinants 13.  
 
In this study, we have explored associations in the SCOPE cohort between maternal BMI during 
pregnancy and childhood BMI and measures of anthropometry as assessed by body fat percentage 
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(BFP), BMI z-score, weight, height, arm, waist and hip circumferences and sum skinfold thicknesses in 
6-year-old children of 1,173 mothers recruited to the study from Auckland, New Zealand (Children of 
SCOPE (CoS) study). With the goal of predicting late pregnancy complications the SCOPE study also 
measured 55 maternal biomarkers, including 15 with relevance to obesity, inflammation, insulin 
resistance and placental function. We have therefore explored whether these biomarkers could play 
a role in the relationship observed between maternal BMI and obesity and childhood adiposity.  
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Methods 
Setting  
Children of SCOPE was a cross-sectional study of 6-year-old children and their mothers who 
participated in SCOPE. These low risk, nulliparous pregnant women were recruited in Auckland, New 
Zealand between November 2004 and August 2008 13. Women were excluded if they were at high risk 
of preeclampsia, or of delivery of small for gestational age infants or preterm birth due to underlying 
medical conditions, had at least three previous miscarriages or terminations of pregnancy, with major 
fetal anomaly or abnormal karyotype prior to recruitment, or if they had received interventions that 
may modify pregnancy outcome. Of the 5,623 women originally recruited in the international SCOPE 
study, 2,032 took part in the Auckland SCOPE study and 1,961 agreed to be contacted for the CoS 
study (Figure 1).  All women with potentially eligible children were contacted. Children with life-
threatening health problems, major congenital abnormalities or chromosomal abnormalities were 
excluded. All women provided written consent for the recruitment of their children. Ethical approval 
was granted by the Auckland Ethics Committee (AKX/02/00/364).  
 
Maternal Data  
For the purposes of this study, we addressed relationships between maternal early-pregnancy BMI 
(primary exposure) and measures of childhood BMI and anthropometry. Maternal BMI was calculated 
from height and weight measured at 15 (standard deviation (SD 0.75)) weeks’ gestation, by research 
staff. To assess the role of potential confounders, we included maternal demographic, clinical and 
lifestyle data obtained at 15 weeks’ gestation, pregnancy outcome data and lifestyle data at the child’s 
follow up (age 6). Details of maternal and childhood variables recorded are provided in the 
Supplementary Table 1.  Women were screened for gestational diabetes mellitus (GDM) at 28 weeks’ 
gestation according to New Zealand guidelines 14. Details of the SCOPE cohort have been previously 
described 15,16. 
Biomarkers 
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Blood samples were taken from all women at 15 (SD 0.75) weeks’ gestation. For the purpose of 
prediction of late pregnancy complications, a total of 55 relevant biomarkers were measured. In the 
CoS study, 15 biomarkers were selected a priori based on known associations with obesity and 
placental function and/or for implications in causal pathways underpinning associations between 
maternal obesity and childhood obesity. A list of these biomarkers is provided in Supplementary Table 
2 and divided into three categories: metabolic (n=7), inflammation (n=4) and growth (n=4).  
 
Childhood Body Fat and Anthropometric Measurements  
BFP was estimated by bioelectrical impedance analysis (BIA (ImpediMed SFB7 tetra polar 
bioimpedance spectroscopy (BIS)); using the weight of the child, the fat mass is derived from fat free 
mass. Fat free mass (FFM) was calculated by: FFM = 0.65 (height2/impedance) + 0.686 * age + 0.15 17. 
BFP was calculated as (weight-FFM)/weight*100. BIA derived fat mass has been previously validated 
against several direct measures of body fat composition 18. Anthropometric measures included BMI-
for-age z-scores 19, height (cm), arm, waist and hip circumferences (cm) and sum skinfold thicknesses 
(triceps, biceps, subscapular and suprailiac, mm). Height was measured in cm with the child standing 
erect on the floor board of a stadiometer with their back to the vertical backboard of a stadiometer 
or wall. Arm circumference was measured at the half way point between the right elbow and the edge 
of the acromion. The waist was measured at the half way point between the top of the hip (iliac crest) 
and lowest rib. Hip circumference was measured as the distance around the maximal diameter of 
buttocks. Skinfold thicknesses were measured using Holtain skinfold callipers. The skinfold thicknesses 
from the 4 sites were summed to give a single measure (sum of skinfold thicknesses, SST). Height, arm, 
waist and hip measurements were taken in triplicate and mean values calculated. Childhood obesity 
was defined as BMI z-score>2SD as recommended by WHO’s child growth standards training (2008) 
20,21.   
Statistical Analysis  
   
8 
 
Single imputation was performed using the median (continuous variables) or mode (binary/categorical 
variables) for variables unrelated to other data points that had <1% missing data in the original SCOPE 
study, described in detail elsewhere15,22. The number of children with complete outcome data is 
n=1162 (99.1%). Maternal sociodemographic characteristics between the available study population 
and the original Auckland SCOPE participants was compared using Chi-square tests, Wilcoxon rank-
sum tests and t-tests as appropriate. Descriptive statistics are presented as mean (SD), frequency 
(percentage) or median (interquartile range) as appropriate.  
 
Linear regression was used to investigate the relationships between maternal BMI and six childhood 
adiposity outcomes (BFP, BMI z-score, height, arm, waist and hip circumference). Two models (A & B) 
were utilised; model A, a simple linear regression with no adjustment for confounders and model B, a 
multiple linear regression including confounders. To aid the selection of confounders in the analysis 
of the relationship between maternal BMI and childhood BMI and adiposity, linear regression was 
used to identify maternal clinical factors and biomarkers associated with childhood adiposity 
outcomes, independent from maternal BMI. Confounders selected for model B, Supplementary Table 
1, were chosen a priori 23 based on known associations with obesity or implication in the causal 
pathway between maternal BMI of childhood obesity. These were decided upon with the use of 
directed acyclic graphs (DAGs, Supplementary Figure 1) 23. Results were corrected for multiple testing 
using Benjamini & Hochberg’s False Discovery Rate (FDR) 24. The variables used in the adjusted model 
were, infant mode of feeding, infant sex and maternal: ethnicity, socioeconomic status, green leafy 
vegetable intake pre-pregnancy, multivitamin use pre-pregnancy, alcohol intake pre-pregnancy, 
cigarette smoking in first trimester, time spent watching television in first trimester, depression in first 
trimester, sleep assessed at 20 weeks’ gestation, maternal hypertension, GDM diagnosis, and 
placental growth factor. 
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For model A and B, the -coefficients for the relationship between maternal BMI and each childhood 
anthropometric measurement are presented as standardised coefficients (SC).  Standardised 
coefficients represented the SD in adiposity measure per SD change in exposure (maternal BMI) 
enabling comparison across outcomes and models. Assumptions for normality were checked for all 
predictors; candidate biomarkers were log transformed (using natural logs).  Data were analysed using 
Stata software, version 15.0 (StataCorp, College Station, Texas).  
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Results  
At follow-up 1,208 (59%) of the 2,032 mothers from the original New Zealand SCOPE participants were 
studied. Although there was no difference observed in BMI, mothers who participated in the CoS study 
were more likely to be older, Caucasian, have a higher education and socio-economic status and were 
less likely to smoke in their first trimester than woman who did not take part; gestational age at 
delivery was similar in both groups, but participants in the follow up were less likely to have delivered 
before 37 weeks’ gestation (Supplementary Table 3).  Of the 1,208 mother-child dyads available for 
analysis, 35 (3%) were excluded due to missing (n=32) or implausible BFP (n=3) (Figure 1).  The study 
population comprised 1,173 mother-child dyads. 
 
Maternal and child characteristics 
Mean (SD) maternal age at baseline (SCOPE study 15 weeks’ gestation visit) was 31 (4) years and most 
(87.6%) women were Caucasian (Table 1). The median BMI was 23.9 kg/m2 (Interquartile range (IQR) 
21.8 to 26.6) and 28.1% (n=329) of women were overweight (BMI >25kg/m2) and 10.1% (n=118) were 
obese (BMI >30kg/m2). Median gestational age at delivery was 40.0 weeks’ (38.9 to 40.9). Mean age 
of the children was 6.0 (0.2) years. Mean child’s BFP was 22.8% (6.3) and BMI z-score was 0.27 (0.91). 
Mean arm, waist and hip circumferences were 18.6 (1.7), 55.4 (4.0) and 61.6 (4.9) cm, respectively, 
and the sum of skinfold thicknesses was 30.5 (9.4) mm. 15.7% (185/1173) were overweight and 3.6% 
(42/1173) of the children were classified as obese according to the WHO definition using BMI 20 (Table 
1).  
 
Maternal early-pregnancy BMI and childhood BMI Anthropometric Measures  
Following adjustment for significant maternal confounders (Supplementary Table 1), maternal BMI 
(measured continuously) was associated with all measures of child adiposity and BMI; BFP (β=0.11 
(95% confidence interval 0.05 to 0.17), p<0.001), BMI z-score (β=0.23 (0.18 to 0.28), p<0.001), arm 
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(β=0.20 (0.14 to 0.25), p<0.001), waist (β=0.17 (0.12 to 0.23), p<0.001), hip circumference (β=0.16 
(0.10 to 0.22), p<0.001) and sum of skinfold thicknesses (β=0.15 (0.09 to 0.21), p<0.001) (Table 2, 
model B). There was no significant difference for height for the models A and B, p=0.4 and p=0.6, 
respectively, furthermore, no interactions were observed between child sex at 6 years of age.  
Early-pregnancy obesity was associated with a 0.63 SD (95% CI 0.46 to 0.80) increase (p<0.001) in 
child’s BMI z-score, in comparison to mothers with normal BMI, after adjustment for confounders 
(Figure 2). Similarly, maternal obesity was associated with 7.8% higher child’s BFP (β=0.27 (0.08 to 
0.47), p=0.006), 4.5% higher mid-arm (β=0.52 (0.33 to 0.72), p<0.001), 3.1% higher waist (β=0.50 (0.30 
to 0.69), p<0.001) 3.1% higher hip circumferences (β=0.42 (0.23 to 0.61), p<0.001) and 11.5% increase 
sum of skinfold thicknesses (β=0.42 (0.23 to 0.61), p<0.001) compared to normal weight mothers 
(Figures 2 and 3).  
 
Biomarkers 
All but one maternal biomarker measured at 15 weeks’ gestation showed no association with 
childhood anthropometric measures. Maternal placental growth factor (PlGF) was positively 
associated with increased child’s hip circumference and SST (p=0.001), Child body fat percentage 
(p=0.009 and BMI z-score (P=0.006) and waist circumference (p=0.02) (Supplementary Table 4).  
Although the relationship between PlGF and arm circumference and BMI z-score did not reach 
statistical significance the point estimates were in the same direction. 
 
Exploratory Analyses 
The evaluation of relationships between maternal variables and offspring adiposity, as assessed by 
simple linear regression and adjusted for multiple testing, provided information on potential 
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confounders for the analysis described above, and described some novel associations of interest 
between maternal PlGF and offspring adiposity (Supplementary Table 4).  
 
Lifestyle and dietary factors during pregnancy  
Smoking during the 1st trimester was associated with increased child body fat β=0.19 (p=0.01), BMI z-
score β=0.30 (p=0.001), arm β=0.37 (p<0.001), waist β=0.26 (p=0.008), and hip circumferences β=0.41 
(p<0.001) and SST β=0.28 (p=0.005). Similarly, children born to women who watched >4 hours of TV 
per day, in comparison to mothers who watched less than 2 hours of TV a day, had higher hip 
circumferences β=0.26 (p=0.04) and were categorised as obese β=3.78 (p=0.01). Conversely, increased 
maternal sleep (measured at 20 weeks’ gestation) was associated with lower child’s body fat β=-0.06 
(p=0.04), BMI β=-0.07 (p=0.01), waist β=-0.06 (p=0.03) and arm circumference β=-0.08 (p=0.009). 
Alcohol during the 1st trimester and multivitamin use pre-pregnancy was associated with lower body 
fat in the child (β=-0.03, p=0.03 and β=-0.15, p=0.01) respectively. Folate use during the 1st trimester 
was not associated with childhood adiposity outcomes.  
 
Obstetric complications 
Gestational hypertension or preeclampsia was associated with increased body fat (p=0.007) at age 6 
years, and gestational diabetes was associated with increased child’s hip circumference (p=0.03), 
independent of maternal BMI.   
 
Postnatal factors  
Girls had higher body fat (p<0.001), arm (p=0.001) and hip (p=0.006) circumferences and SST 
(p<0.001), and decreased height (p=0.001) compared to boys. Independent of maternal BMI, exclusive 
breastfeeding at hospital discharge was associated with decreased body fat (p=0.03) at age 6 years.  
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Ethnicity and Sociodemographic  
Māori and Pacific women had a higher BMI compared to their Caucasian counterparts (median 
30kg/m2 and 26 kg/m2 respectively vs 24 kg/m2, p<0.001). Similarly, children born to women identified 
as Māori and Pacific Islanders had higher BFP (p=0.03), BMI z-score (p<0.001), arm (p=0.007), waist 
(p<0.001) and hip circumferences (p<0.001) and SST (p=0.03) and were more likely to be overweight 
or obese (p<0.001) in comparison to mothers identified as Caucasian. Maternal low socioeconomic 
status was also associated with increased BFP (p=0.03), BMI z-score (p=0.003), arm (p=0.04) and waist 
circumferences (p=0.03) and risk of obesity at age 6 years (p=0.09), in comparison to ‘normal’ 
socioeconomic status (New Zealand Socio-economic Index score between 32 to 55).  
 
 
 
 
 
 
 
 
Discussion  
This study supports the hypothesis that maternal obesity in early pregnancy is associated with 
offspring BMI and measures of adiposity at six years of age. We confirm a robust relationship between 
maternal BMI and childhood adiposity through multiple and complementary estimates of childhood 
fat mass in a large contemporary mother-child cohort of New Zealand low risk nulliparous women, of 
whom 38% were overweight or obese in early pregnancy.   
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The observed effects for all child adiposity outcomes in SCOPE study were not explained by numerous 
maternal environmental and lifestyle confounders which included maternal sleep duration, 
depression, socioeconomic status and breastfeeding practice, suggesting intrauterine mechanisms 
may exert a considerable influence on later adiposity in this cohort with a large portion of obese or 
overweight women at the time of early pregnancy. In regard to previous cohort studies, 38% (n=447) 
of the SCOPE cohort women who returned for the 6 year follow-up were overweight or obese 
compared to 28% in the Generation R study cohort and 16% in the ALSPAC cohort 8,25. When compared 
with Generation R studied between 2001 and 2006, the standardised effect size of the relationship 
between maternal BMI and child’s BMI was larger in the NZ children aged 6 years (β=0.23 vs β=0.14) 
7 which may reflect the higher incidence of overweight and obesity in the NZ children studied almost 
a decade later (2011-2014). The present study suggests that children of overweight mothers are likely 
to have a 0.4kg/m2 increase in BMI and in those of mothers affected by obesity this rises to an increase 
of 1.0kg/m2 compared to children of normal weight mothers. Long term follow-up studies have found 
that even modest centile variation in early life BMI is associated with greater cardiovascular disease 
in adulthood 26.  Previous studies have also shown that weight management programmes in adults 
have successfully shown a reduction of 1 kg/m2 in BMI. Our study suggests that if this were to be 
achieved in women with overweight or obesity prior to pregnancy  27 , this would reduce the risk of 
increased infant adiposity. It is therefore plausible that the effect sizes found are meaningful at a 
population level. Moreover, overweight or obesity during early infancy or childhood is associated with 
poorer cardiovascular and metabolic outcomes during childhood and a higher risk of obesity in later 
life 8,28–35 this study adds to an increasing literature from human cohorts and animal models to suggest 
that many common disorders may have origins in the earliest stages of life. Although this study 
indicates an independent relationship between maternal BMI and offspring BMI, well recognised 
childhood exposures will inevitably contribute to obesity in the children, providing a second hit, and 
compounding the risk of adulthood obesity and related morbidities. 
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Whilst dual-energy x-ray absorptiometry is often considered the gold standard of adiposity 
measurement, we found that childhood WHO BMI-for-age adjusted z-scores demonstrated the 
highest standardised beta coefficient in the relationship between maternal obesity and childhood 
obesity, when compared to body fat percentage as measured by polar BIS and also arm, waist and hip 
circumferences and SST.  
 
Mechanistically a number of in utero ‘exposures’ have been implicated in the causal pathway linking 
maternal obesity to childhood obesity; these include inflammatory markers, dyslipidaemia, 
hyperinsulinaemia and hyperleptinaemia which, it has been suggested, may permanently reset the 
fetal adipoinsular axis or pathways of energy balance resulting in adiposity and altered energy 
homeostasis during childhood 36–38.  In this study we found no association with any measure of infant 
adiposity and biomarkers of the inflammatory response measured at 15 weeks of pregnancy, including 
- C reactive protein, intercellular adhesion molecule 1, interleukin 1 receptor antagonist and 
macrophage migration inhibitory factor. Neither was there any association with maternal lipids (total 
cholesterol, HDL-cholesterol or LDL cholesterol and triglycerides) or with the adipokines, leptin and 
adiponectin, or insulin. The positive association of the angiogenic factor, PlGF with measures of child 
SST adiposity has to our knowledge not previously been reported. These associations may reflect that 
PlGF is a marker of healthy placental function, associated with placental angiogenesis and reduced 
vascular resistance 39 . Theoretically, higher PIGF and reduced placental vascular resistance could 
enhance nutrient transport and predispose the child to increased adiposity and later obesity. Of 
relevance, a recent study addressing the relationship between later pregnancy PlGF and infant birth 
weight found a significant association between PlGF and macrosomia, although this was an 
investigation of mothers with pre-existing diabetes 40.  
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Our findings confirm the association between mothers identified as Māori or Pacific Islanders and 
increased offspring adiposity as recently shown in The Early Life Factors study which recruited women 
during 2008 to September 2011 in Wellington, Auckland and Christchurch, New Zealand 41. A later 
study, the New Zealand Heath Survey (2015/2016) reported that 60% of Pacific and 44% of Māori 
children affected by were overweight or obesity in comparison to 30% of children aged between 5 to 
9 42. We found that the rate of obesity in Pacific and Māori children was approximately 4 and 6 times 
higher respectively than those identified as ‘Caucasian’. These findings highlight that the relationship 
between ethnicity and maternal weight during pregnancy and obesity risk continues through 
childhood and demonstrate an urgent need for prevention strategies targeting high-risk ethnic 
pregnant women in these populations.  
 
We found an inverse association between maternal alcohol use in the 1st trimester and body fat 
percentage at age 6 years following adjustment for confounders. Heavy alcohol exposure during early 
life or pre-pregnancy is associated with reduced birthweight and adverse pregnancy outcomes 43,44 
which may have a persistent influence on childhood growth. A recent study of over 7,000 British 
mother-child dyads (ALSPAC birth cohort) demonstrated a similar association in young children, 
however this was no longer evident at the age of 10 years 45. Previous reports have suggested that the 
relationship between excess maternal alcohol intake and delayed weight in later childhood may be 
explained by maternal nutritional intake, genetics, socioeconomic status and ethnicity 46.  
 
We also found associations between gestational hypertension and offspring body composition 
independent of maternal BMI. Higher blood pressure may reflect poor placental function; resulting in 
increased risk of childhood metabolic outcomes and obesity. Similar results have been reported in a 
cohort of 618 mother and child dyads 47, the authors found associations between maternal 
hypertension and offspring risk of overweight or obesity at 4 years of age. Similarly there are previous 
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reports of an association between maternal GDM and offspring adiposity, although, a recent 
systematic review concluded that the relationship between GDM and offspring BMI z-score was not 
evident following adjustment for maternal BMI 48. 
 
Strengths  
Research midwives conducted interviews prospectively with pregnant women using a detailed 
standard operating procedure, and a database that incorporated automated data queries. There was 
a high follow up rate and minimum missing data in the extensive dataset of pregnant women in the 
original Auckland SCOPE study; a key strength of this study. The Children of SCOPE study of mother-
child dyads was purposely designed to assess childhood obesity; strength lies in the rigorous 
assessment of adiposity and richness of data for potential confounders in mothers recorded in a 
narrow window in early pregnancy (15±0.75 weeks’ gestation), and at follow up of children at 6 years 
born to a heterogeneous cohort of low risk women. 
Limitations  
Follow up data was available for 1,208 (59%) mothers from the original Auckland SCOPE study, which 
could result in biased estimates if associations between maternal BMI and childhood adiposity differ 
between those included and not included. The participants in the Auckland SCOPE study were not 
representative of women giving birth in Auckland. There were more Caucasians, well-educated 
women and non-smokers than the general pregnant population and under representation of Māoris. 
Residual confounding due to unmeasured maternal lifestyle related variables, common genetic 
variants related to obesity in mother and child. Our analyses found a strong relationship between 
maternal and childhood obesity, although a limitation is that we were not able to examine the child’s 
obesity polygenic risk score (PRS) as an explanation for the finding, but other studies suggest that 
genetic influences, reflected in PRS, are unlikely to have anything more than a modest influence on 
the association 49. The measures of body composition utilised in this study have limitations. BMI which 
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was used to define obesity in the mothers is an indirect measure fat mass. For the children 
Bioelectrical Impendence Analysis was not validated against DEXA, a gold standard for measuring 
adiposity. Furthermore, the observational study design may overestimate the effect of intrauterine 
exposures and limit causal inferences. Previous studies have also reported an association of maternal 
BMI with offspring adiposity, which is mediated through gestational weight gain9,50,51.  A limitation of 
this study is that we did not routinely measure gestational weight gain and were therefore unable to 
assess the impact on childhood BMI. This is mitigated somewhat by the results of a recent individual 
participant meta-analysis of 162,129 mothers and children from 37 pregnancy and birth cohorts which 
reported small effects of GWG on childhood overweight/obesity comparison to a much greater 
influence of maternal BMI per se 52.  
 
Conclusions  
This investigation from a large contemporary, detailed prospective mother-child cohort study with 
multiple measures of childhood fat mass provides robust evidence for an independent relationship 
between maternal BMI in early pregnancy and childhood adiposity at 6 years of age. Whilst we have 
recently shown that a maternal behavioural intervention in pregnant women with obesity has the 
potential to reduce infant adiposity and to produce a sustained improvement in maternal diet at 6 
months postpartum (UK Pregnancies Better Eating and Activity randomised controlled Trial)12, the size 
effect was modest and further trials with more effective maternal interventions are required to 
elucidate causality.  
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Figures 1: Flow Diagram of Study population  
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Figure 2. Box and whisker plots of maternal body mass index categories at 15 weeks’ gestation by child’s body fat percentage and Child’s BMI z-
score. Box plots excludes women who were underweight (n=9) and outside values. Sample size n=1164 (healthy BMI (18.5 to 24.9 kg/m2) n=717, 
overweight (25 to 29.9 kg/m2) n=329 and obese (30 kg/m2) n=118). In an adjusted model, maternal early-pregnancy overweight (p=0.01 and 
p<0.001) and obesity (p=0.006 and p<0.001) is associated with childhood body fat percentage and BMI z-score, respectively, at age 6 years in 
comparison to ‘normal’ BMI mothers. 
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Figure 3. Box and whisker plots of maternal body mass index categories at 15 weeks’ gestation by child’s anthropometry at age 6 years. child’s arm 
circumference (cm), child’s waist circumference (cm), child’s hip circumference (cm), child’s sum of skinfold thicknesses (mm). Sample size n=1,164. Healthy 
BMI (18.5 to 24.9 kg/m2) n=717, overweight (25 to 29.9 kg/m2) n=329 and obese (≥30 kg/m2) n=118. After adjustment for confounders for children at 6 years 
of age arm, waist and hip circumferences were associated with maternal early-pregnancy overweight (p<0.001) and obesity (p<0.001). Child’s sum of skinfold 
was also associated with maternal early-pregnancy overweight (p<0.06) and obesity (p<0.001) in comparison to ‘normal’ BMI mothers,  
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Table 1: Maternal, infant and childhood characteristics, lifestyle and pregnancy outcomes in the Children of 
SCOPE study (n=1173) 
Maternal characteristics at 
baseline (15 weeks of pregnancy) 
Mean (SD), 
median (IQR) or 
frequency (%) 
 
Mean (SD), 
median (IQR) or 
frequency (%) 
Age (years)  31.0 (4.3) Depression d (EPDS) (n=1170) 6.6 (4.3) 
BMI*   23.9 (21.8-26.6) Stress e (PSS) (n=1166) 14.3 (5.9) 
BMI (categorical)   Anxiety e (STAI) (n=1170) 32.0 (10.3) 
    < 18.5  9 (0.8%) High consumption of vegetables f 167 (14.2%) 
    18.5 to 24.9  
717 (61.1%) 
Hours TV watched / day e, g 
(n=1170) 
1 
   25.0 to 29.9 329 (28.1%)      <2  497 (42.5%) 
   > 30+ 118 (10.1%)     2 to 4 601 (51.4%) 
Maternal ethnicity      >4 72 (6.2%) 
Caucasian 1027 (87.6%) Pregnancy outcomes  
Asian 45 (3.8%) Premature birth h  70 (5.9%) 
Indian 40 (3.4%) Gestational age (weeks)* 40.0 (38.9-40.9) 
Māori 34 (2.9%) Birthweight (grams)* 
3470 (3140- 
3790) 
Other  16 (1.4%) 
Breastfeeding exclusively at 
discharge postpartum (n=1172) 
881 (75.2%) 
Pacific 11 (0.9%) Characteristics at follow up  
Maternal SES (NZSEI)  Maternal BMI* (n=1172) 24.1 (21.8-27.8) 
high 324 (27.6%) Maternal BMI (categorical)   
medium 694 (59.2%)     < 18.5  23 (2.0%) 
low  155 (13.2%)     18.5 to 24.9  640 (54.6%) 
Education (years)     25.0 to 29.9 336 (28.7%) 
<12 65 (5.5%)    > 30+ 173 (14.8%) 
12 to 13 1089 (92.8%) Child's age 6.0 (0.2) 
>13 19 (1.6%) Child's sex (female) 587 (50.0%) 
Marital status  Child's weight (kg)* 21.7 (20.0-23.7) 
Married 842 (71.8%) Child's height (cm)i 117.9 (4.9) 
De facto a  296 (25.2%) Child's BMI (z-score) 0.27 (0.91) 
Single 
27 (2.3%) 
Child overweight (BMI z-score 
>1SD <2SD)l 
185 (15.7%) 
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Same sex partner 6 (0.5%) Child obese (BMI z-score >2SD)l 42 (3.6%) 
Separated or divorced  2 (0.2%) Child’s body fat (%) 22.8 (6.3) 
Smoking in at 15 weeks’ 110 (9.4%) Child’s arm circumference (cm)i  18.6 (1.7) 
Alcohol b (n=1160)  631 (54.4%) Child’s waist (cm) i 55.4 (4.0) 
Folate use e  870 (74.1%) Child’s hip (cm) i 61.6 (4.9) 
Multivitamin use c (n=1163) 391 (33.6%) Child’s triceps (mm) i (n=1163) 10.7 (3.2) 
Hypertension 61 (5.2%) Child’s biceps (mm)i (n=1163) 7.2 (2.5) 
GDM (n=1078) 19 (1.8%) 
Child’s subscapular 
(mm)i(n=1162) 
6.2 (2.1) 
Sleep/ hours at night on weekdays 
d (n=1167) 
8.1 (1.14) Child’s suprailiac (mm)i (n=1163) 6.5 (2.9) 
  Child’s sum of skinfolds k (mm)  30.5 (9.4) 
Abbreviations: SES - socio-economic status, NZSEI - New Zealand Socio-Economic Index (10 to 31 low, 32 to 55 medium, 56 to 90 high), 
BMI - body mass index, GDM – Gestational Diabetes Mellitus, EPDS - Edinburgh Postnatal Depression Scale (continuous, 0 to 30), PSS - 
Perceived Stress Scale (continuous, 0 to 40), STAI – adapted State-Trait Anxiety Inventory (continuous, 20 to 80); a stable relationship, 
not married; b alcohol exposure in the 1st trimester (yes/no); c any use pre-pregnancy; d hours at night, weekdays; eat 15 weeks of 
pregnancy; f High consumption of green leafy vegetables 3+ times per day 1 month prior to conception; g per day in the last month; h <37 
weeks; i mean of triplicate measurements; k sum of triceps, biceps, subscapular and suprailiac *median, quartiles, l World Health 
Organisation (2007) 
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Table 2: Association between early-pregnancy maternal body mass index (BMI) and childhood anthropometric measures at age 6, multivariate analysis  
 Model A (unadjusted) Model B (adjusted) 
Measure of childhood adiposity at age 6 
years 
n Standardised coefficient 
(β) (95% CI) 
P value n Standardised 
coefficient (β) (95% CI) 
P value 
Percentage body fat 1173 0.15 (0.10 to 0.21) <0.001 1143 0.11 (0.05 to 0.17) <0.001 
BMI z-score a 1173 0.25 (0.20 to 0.30) <0.001 1167 0.23 (0.18 to 0.28) <0.001 
Height (cm) 1173 0.03 (-0.03 to 0.08) 0.4 1170 0.02 (-0.04 to 0.07) 0.6 
Arm (cm)  1173 0.22 (0.17 to 0.28) <0.001 1164 0.20 (0.14 to 0.25) <0.001 
Waist (cm) 1173 0.20 (0.14 to 0.26) <0.001 1167 0.17 (0.12 to 0.23)   <0.001 
Hip (cm) 1173 0.20 (0.14 to 0.25) <0.001 1072 0.16 (0.10 to 0.22)   <0.001 
Sum of skinfolds (mm) b  1162 0.17 (0.11 to 0.22) <0.001 1159 0.15 (0.09 to 0.21) <0.001 
Obese (BMI z-score >2SD) c 1173 1.11 (1.05 to 1.18) <0.001 1104 1.08 (1.03 to 1.15) 0.005 
Standardised coefficient (β), representing the standard deviation (SD) change and 95% confidence interval in adiposity measure per SD change in exposure enabling comparison across outcomes 
and models; Model A (simple regression) - univariate association between maternal BMI (at 15 weeks’ gestation) and childhood adiposity at age 6 years, Model B (multiple regression) - maternal 
BMI in association with childhood adiposity, each outcome adjusted for infant mode of feeding, infant sex and maternal: ethnicity, socioeconomic status, green leafy vegetable intake pre-
pregnancy, multivitamin use pre-pregnancy, alcohol intake pre-pregnancy, cigarette smoking in first trimester, time spent watching television in first trimester, depression in first trimester, sleep 
assessed at 20 weeks’ gestation, maternal hypertension, GDM diagnosis, and placental growth factor.; a World Health Organisation (2007) BMI for age z-score; bsum of triceps, biceps, subscapular 
and suprailiac skinfold thicknesses (mm); c odds ratio  
